Fredun Pharmaceuticals Share Price | Fredun Pharmaceuticals Stock Screener
FREDUN
Pharmaceuticals
Share Price BSE
₹895.20
▼
-1.10 (-0.12%)
As of July 24, 2026, the Fredun Pharmaceuticals share price (BSE: FREDUN) is ₹895.20, down 0.12% from the previous close, with shares trading between ₹851.70 and ₹909.95, and a 52-week range of ₹885.75–₹2,857.55.
Analyse FREDUN stock price history and track historical price performance.
Use the Fredun Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Fredun Pharmaceuticals Market Cap
₹1,515.88 Cr.
FREDUN P/E Ratio (TTM)
46.99
Fredun Pharmaceuticals P/B Ratio
5.69
EPS (TTM)
₹66.81
Dividend Yield
0.02%
Debt to Equity
0.93
FREDUN 52 Week High
₹2857.55
Fredun Pharmaceuticals 52 Week Low
₹885.75
Operating Margin
12.00%
Profit Margin
5.24%
FREDUN Revenue (TTM)
₹210.00
EBITDA
₹26.00
Net Income
₹11.00
Total Assets
₹642.00
Total Equity
₹278.00
Fredun Pharmaceuticals Share Price Chart
Screen Fredun Pharmaceuticals share price with an interactive chart. Analyse FREDUN price trends and volatility across different timeframes.
Fredun Pharmaceuticals Company Profile - Fundamental Screener
Screen Fredun Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for FREDUN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE194R01017
Fredun Pharmaceuticals Balance Sheet Screener
Screen FREDUN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 |
|---|---|---|
| Assets | ||
| Total Assets | 642 | 487 |
| Current Assets | 498 | 427 |
| Fixed Assets | 118 | 53 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 67 | 18 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 278 | 141 |
| Share Capital | 6 | 5 |
| Reserves & Surplus | 259 | 137 |
Fredun Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Fredun Pharmaceuticals income statement and profit fundamentals.
Analyze FREDUN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Fredun Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Revenue | 210 | 160 | 144 | 119 | 165 | 286 | 0 | 0 |
| Expenses | 184 | 135 | 123 | 103 | 150 | 251 | 0 | 0 |
| EBITDA | 26 | 25 | 21 | 17 | 15 | 35 | 0 | 0 |
| Operating Profit % | 12.00% | 16.00% | 14.00% | 14.00% | 9.00% | 12.00% | 0.00% | 0.00% |
| Depreciation | 3 | 2 | 2 | 1 | 2 | 3 | 0 | 0 |
| Interest | 15 | 11 | 8 | 7 | 8 | 14 | 0 | 0 |
| Profit Before Tax | 11 | 14 | 13 | 9 | 7 | 20 | 0 | 0 |
| Tax | 1 | 4 | 3 | 2 | 1 | 7 | 0 | 0 |
| Net Profit | 11 | 11 | 9 | 7 | 6 | 14 | 0 | 0 |
| EPS | 19.70 | 22.19 | 19.98 | 14.33 | 12.71 | 29.09 | 0.00 | 0.00 |
Fredun Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen FREDUN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March |
|---|---|---|
| Operating Activities | 12 | -17 |
| Investing Activities | -74 | -6 |
| Financing Activities | 121 | 27 |
| Net Cash Flow | 60 | 4 |
Fredun Pharmaceuticals Shareholding Pattern Screener
See Fredun Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Fredun Pharmaceuticals promoter holding and ownership changes for FREDUN on TickJournal.
| Item | 2026-Feb | 2026-Mar | 2026-Jun | 2026-Jul | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.06% | 44.17% | 44.57% | 44.57% | 48.93% | 48.93% | 48.93% | 43.06% |
| FII Holding | 1.06% | 1.06% | 1.06% | 1.06% | 0.00% | 0.00% | 0.01% | 0.46% |
| DII Holding | 2.89% | 2.83% | 2.94% | 2.94% | 1.59% | 1.59% | 1.60% | 3.48% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.63% | 44.66% | 43.79% | 43.62% | 44.50% | 44.52% | 43.74% | 45.18% |
| Other Holding | 7.37% | 7.28% | 7.65% | 7.81% | 4.98% | 4.96% | 5.72% | 7.83% |
| Shareholder Count | 8,443 | 8,400 | 8,903 | 9,598 | 7,976 | 7,906 | 8,120 | 8,749 |
Fredun Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Fredun Pharmaceuticals dividend history with payout and yield data.
View Fredun Pharmaceuticals dividend details including ex-dates and amounts for FREDUN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.70 | 0.08% |
| 2025-March | ₹0.70 | 0.13% |
| 2024-March | ₹0.70 | 0.31% |
| 2023-March | ₹0.70 | 0.29% |
| 2022-March | ₹0.70 | 0.27% |
| 2021-March | ₹0.70 | 0.23% |
| 2020-March | ₹0.66 | 0.43% |
| 2019-March | ₹0.65 | 1.67% |
| 2018-March | ₹1.00 | 0.71% |
| 2017-March | ₹0.60 | 1.26% |
Fredun Pharmaceuticals Stock Index Membership
See which indices include Fredun Pharmaceuticals stock.
Check FREDUN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Fredun Pharmaceuticals Market Events Screener - Corporate Actions
Get Fredun Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Fredun Pharmaceuticals stock events that may affect FREDUN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-16 | 2026-07-16 | Bonus | 2:1 | 7.27% |
| 2026-06-30 | 2026-06-30 | Annual General Meeting | NA | 18.48% |
| 2026-06-23 | 2026-06-23 | Dividend | ₹ 0.70 /share | 1.92% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 5.79% |
| 2026-02-16 | 2026-02-16 | Extraordinary General Meeting | NA | 21.57% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 10.64% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -9.98% |
| 2025-10-22 | 2025-10-22 | Extraordinary General Meeting | NA | 27.12% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 8.06% |
| 2025-09-23 | 2025-09-23 | Dividend | ₹ 0.70 /share | 57.68% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 11.44% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 6.41% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 3.02% |
| 2024-10-26 | 2024-10-26 | Quarterly Result Announcement | NA | -6.18% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -4.13% |
Fredun Pharmaceuticals Competitors Screener - Peer Comparison
Screen FREDUN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 470,726 | 40.78 | 61,674 | 12.69% | 11,565 | 68.02 |
| Divis Laboratories | 194,588 | 75.69 | 11,067 | 13.95% | 2,568 | 71.98 |
| Torrent Pharmaceuticals | 191,732 | 79.19 | 13,886 | 20.34% | 2,138 | 66.68 |
| Cipla | 115,724 | 30.16 | 29,045 | 2.24% | 3,870 | 52.50 |
| Zydus Life Science | 115,023 | 22.33 | 27,658 | 17.64% | 5,026 | 58.19 |
| Lupin | 114,985 | 21.16 | 29,039 | 26.75% | 5,356 | 63.60 |
| Mankind Pharma | 106,532 | 54.68 | 14,636 | 14.85% | 1,938 | 60.75 |
| Dr Reddys Laboratories | 100,661 | 24.56 | 35,059 | 3.90% | 4,158 | 32.84 |
| Aurobindo Pharma | 90,892 | 25.88 | 33,385 | 3.21% | 3,376 | 58.93 |
| Laurus Labs | 86,010 | 94.61 | 6,868 | 22.01% | 890 | 67.71 |
Fredun Pharmaceuticals Company Announcements - News Screener
Screen FREDUN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-07-10 | Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issue Of Bonus Equity Shares. | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-06-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-06-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-06-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-06-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-08 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations"). | - |
| 2026-06-08 | Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26 | - |
| 2026-06-08 | Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM). | - |
| 2026-06-08 | Notice Convening 39Th Annual General Meeting (AGM) Of Fredun Pharmaceuticals Limited | - |
| 2026-06-08 | Reg. 34 (1) Annual Report. | - |
| 2026-06-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |